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Background: We have recently demonstrated that an obese-years construct is a better predictor of the risk of
diabetes than the severity of body weight alone. However, these risk estimates were derived from a population
cohort study initiated in 1948 that might not apply to the current population.
Objective: To validate an obese-years construct in estimating the risk of type-2 diabetes in a more
contemporary cohort study.
Design: A total of 5,132 participants of the Framingham Offspring Study, initiated in 1972, were followed up
for 45 years. Body mass index (BMI) above 29 kg/m2 was multiplied by the number of years lived with obesity
at that BMI to define the number of obese-years. Time-dependent Cox regression was used to explore the
association.
Results: The risk of type-2 diabetes increased significantly with increase in obese-years. Adjusted hazard ratios
increased by 6% (95% CI: 57%) per additional 10 points of obese-years. This ratio was observed to be similar
in both men and women, but was 4% higher in current smokers than in never/ex-smokers. The Akaike
Information Criterion confirmed that the Cox regression model with the obese-years construct was a stronger
predictor of the risk of diabetes than a model including either BMI or the duration of obesity alone.
Conclusions: In a contemporary cohort population, it was confirmed that the obese-years construct is
strongly associated with an increased risk of type-2 diabetes. This suggests that both severity and the duration
of obesity should be considered in future estimations of the burden of disease associated with obesity.
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Introduction
Approximately 1.12 billion individuals globally will be-
come obese in the next decade (1). In some countries, such
as the United States, 34.9% (78.6 million) of adults and
17% (38.3 million) of youths are now obese (2). If current
secular trends continue, obesity will be a burden on health
systems worldwide (3), as it is strongly associated with an
increased risk of type-2 diabetes and other chronic diseases
(4). A meta-analysis found that people with obesity have
a seven-fold higher risk of type-2 diabetes compared to
those with normal weight (5). Therefore, not surprisingly,
obesity has been blamed for the current epidemic of type-2
diabetes worldwide (6). Today, there are an estimated 415
million people living with diabetes, including 193 million
who are undiagnosed, while a further 318 million adults
have impaired glucose tolerance, which increases the riskof
diabetes. If the current obesity trend continues unabated,
diabetes will cause more than 5 million deaths and cost
1,000 billion dollars in healthcare spending (7), threaten-
ing global economies in both developed and developing
countries (8).
The future burden of diabetes may be underestimated if
the adverse effect of obesity is not totally captured. The
current analysis of the burden of diseases relies mostly on
the severity of obesity, or the duration of obesity only. A
combination of both the severity and duration of obesity
into a single measurement of obese-years has been ignored.
We recently proposed a new approach of calculating the
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total adverse effect of obesity (9), in which the cumulative
risk for a person with mild obesity for a long period of time
is considered similar to that for more severe obesity for a
shorter period of time. This approach is analogous to
smoking-related studies in which the total adverse effects
of the combined quantity of cigarettes or packs smoked per
day and the duration of smoking, expressed as cigarette-
years or pack-years (1012) has been well recognized.
Recently, two studies have reported that an obese-years
construct is a better and more concise estimation the risk
of type-2 diabetes (9) and cardiovascular disease (13),
compared with a construct based on either the duration
or severity of obesity alone. However, those studies have
some limitations, as the population used relied on the
relatively old prospective cohort of the original Framing-
ham Heart Study (FHS) that began in 1948. In the 1950s,
the prevalence of obesity in America was still relatively
low (14). Nowadays, the prevalence of obesity is signifi-
cantly higher. Moreover, the number of years of living
with obesity is also increasing as the onset of obesity is
occurring earlier, even in childhood. Therefore, the pre-
vious estimation of the risk of type-2 diabetes (9) might not
apply to current population characteristics.
The primary aim of this study was to calculate the
association between the obese-years construct and risk of
type-2 diabetes in a more contemporary population cohort
study using the Framingham Offspring Study (FOS).
In FOS, adult children of the original FHS members and
their spouses were followed up from 1971 for over 45 years.
During the follow-up, the participants underwent regular
physical examinations. The secondary aim was to examine
whether a model with the obese-years construct offers a
better goodness of fit for estimating the risk of type-2
diabetes than separate models based on either body mass
index (BMI) or the duration of obesity alone.
Methods
Source of data
We used data from the FOS in this prospective cohort
study of the offspring of the original cohort of FHS
and their spouses. The original cohort of the FHS began
in 1948 and aimed to identify the common risk factors
associated with cardiovascular disease (15). In 1971, 3,548
adult children of the original FHS members and 1,576
of their spouses aged of 570 years were added into a
new study, called the FOS. The main objective of the FOS
was to examine the secular changes in the levels of risk
factors between the two generations (16). A total of 5,227
participants of the FOS were followed up for approxi-
mately 45 years. The latest examination (examination 9)
began in April of 2011 and concluded in April of 2014. For
this study, data was only available until examination 8.
Measurement of variables
In the FOS, extensive physical examination, laboratory
tests, health behaviors interviews, and medical history and
illness conditions were measured regularly, approximately
every 3 to 8 years using a standardized protocol. Obesity
was defined using the World Health Organization’s BMI
cut-off point for obesity (17), a BMI of 30 kg/m2 or
greater. Demographic variables of age, sex, education, and
marital status are included in the analysis as covariates.
The age of participants was defined as years from date
of birth to the date of examination. Education was
defined as the number of years of schooling. Marital
status was grouped into three categories (single, married,
and widowed, divorced or separated) and it was measured
at examination 2, 4, 5, 7, and 8. Health behavior variables
of smoking status (current smokers and never/ex-
smokers) and number of cigarettes smoked per day,
number glasses of alcoholic drinks per week (beer, white
wine, red wine, or liquor), and number of hours of physical
activity were included in the analysis. Current smoker
was defined a participant who had smoked regularly in
the past year. Alcohol consumption was measured in
standards glasses per week. In the FOS, a participant
was asked for the number of hours for rest (sleep and
sedentary, such as reading watching TV) and physical
activity for a typical day (most days of the week) in 24 h.
Physical activity included the number of hours of slight
activity, such as standing and walking; moderate activity,
such as housework (e.g. vacuuming, dusting, doing yard
chores, climbing stairs) and light sports (e.g. bowling,
golf); and heavy activity, such as heavy household or yard
work (e.g. stacking or chopping wood) and exercise
and intensive sports (e.g. jogging, swimming). These
categories were not mutually exclusive.
The measurement of obese-years
Obese-years was constructed by combining the severity of
obesity and the duration of obesity into a single variable.
Obese-years was calculated by the severity of obesity
(in ‘obese units’, equivalent to BMI units (kg/m2) at each
examination by the duration of obesity (the number years
lived with obesity). At each examination, the cumulative
number of obese-years was computed as the sum of all
obese-years ‘exposure’ up to that examination. The severity
of obesity was calculated as follows: (1) if BMI B30 kg/m2,
the severity was zero; and (2) if BMI ]30 kg/m2, the
severity was BMI minus 29 kg/m2. For example,
if BMI was 34 kg/m2, the severity was 5 (34) obese units.
The number years lived with obesity (obesity duration)
was defined from the onset of obesity as the date of
the first examination at which the individual was obese
and, from that time, the individual was considered to be
continuously obese until a non-obese examination, after
death, the end of follow-up. A participant could have
multiple periods of obesity during the study follow-up.
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Table 1 illustrates the calculation of obese-years for a
single individual. This participant first had a measure-
ment of obesity at examination 2 and was assigned an
obesity duration of zero at this examination. At examina-
tion 3, this participant was assumed to have lived with
obesity for 4.7 years (the time interval between examina-
tions 2 and 3), with a degree of obesity of 1.5 kg/m2. This
approach assumes that an individual’s BMI is carried
forward from a given examination (i.e. examination 2) and
does not change until a different BMI value is recorded
at a subsequent examination (i.e. examination 3). The
number of obese-years at examination 3 was therefore
7.1 obese-years (1.5 BMI unit4.7 years in the preceding
interval). From examinations 3 to 4 (a 3-year interval),
the participant was still obese with a degree of obesity of
3.6 kg/m2 (BMI 32.6 kg/m2). At examination 4, the
number of obese-years was 10.8 (3.6 BMI unit3 years)
and the cumulative obese-years at this examination was
17.9 obese-years (7.1 plus 10.8). This method implies that
individuals accumulating 40 obese-years, for example,
could have reached this quantity either by having been
obese with a BMI of 30 kg/m2 for approximately 40 years
or by having been obese with BMI of 33 kg/m2 for approxi-
mately 10 years or, indeed, many other combinations.
Measurement of the outcome and time to event
The main outcome of this analysis was type-2 diabetes. A
person was diagnosed with type-2 diabetes if their fasting
plasma glucose levels were greater than 126 mg/dL
(7 mmol/L), or he or she was treated with insulin or an
oral hypoglycemic agent at a given examination. For the
purpose of this study, those who had been diagnosed as
having type-2 diabetes at baseline (n95) were excluded
from analysis. Participants who died, lost to follow-up, or
reached the end of the study follow-up (examination 8)
without a diabetes diagnosis were censored at the date of
death, lost to follow-up, or examination 8.
Statistics data analysis
A dynamic survival model (18), with time-dependent
Cox proportional hazards (19, 20), was deployed. Most
variables included in the model were time-varying, except
for sex and ethnicity, which did not vary during the study
follow-up. To handle the time-varying variables in the
analysis, the structure of the dataset was transformed (or
reshaped) from wide to long and captured the variation
of values of variables during study follow-up, and a
time-dependent (extended) Cox regression analysis was
performed. In a time-dependent Cox regression, the
follow-up time for each participant is divided into dif-
ferent time windows (i.e. the interval of examinations).
For each time window, a separate Cox analysis is carried
out using the specific value of the time-dependent variable
at the beginning of that specific time window. A weighted
average of all the time windowspecific results is calcu-
lated. This weighted average of a series of relatively short-
term effects is presented as the result of the analysis as a
single hazard ratio (HR). More detail on this approach
has been described by Dekker et al. (21).
The obese-years construct was analyzed both as a
continuous and categorical variable. The categorical
variable was categorized into five groups of obese-years
(0, 124.9, 2549.9, 5074.9, and ]75). For the contin-
uous variable of obese-years, HRs were presented per
additional 10-unit increase of obese-years, where a one-
unit increase in obese-years can represent an additional
BMI level above ]30 kg/m2 or an additional year
lived with obesity at a given BMI level. These categories
were used to make the results of this study similar to
the categories of previous findings (9, 13), to facilitate
comparison. Analyses were performed for total partici-
pants but also for categories stratified by gender and
smoking status (current and never/ex-smokers,) as pre-
vious findings showed some variation in the relationship
between obese-years and the risk of type-2 diabetes
by gender and by smoking status (9). Two main models
were employed to examine the effect of possible confoun-
ders on the relationship between the obese-years construct
and incident type-2 diabetes. Model 1 was adjusted for
the demographic variables of age, sex, marital status,
and educational level. Model 2 was adjusted for these
Table 1. Illustration of the calculation of an obese-years metric for a single hypothetical individual
ID Examination
Date of
examination
Interval between
examinations, yearsa
Body mass
indexb
Degree of
obesity
Duration of
obesity, years
Obese-
yearsa
Cumulative
obese-years
3 1 (baseline) 02-Apr-73  28.3 0  0 0
3 2 16-Mar-81 8.0 30.5 1.5 0 0 0
3 3 15-Nov-85 4.7 32.6 3.6 4.7 7.1 7.1
3 4 23-Nov-88 3.0 34.4 5.4 3.0 10.8 17.9
3 5 31-Aug-92 3.8 32.7 3.7 3.8 20.5 38.4
3 6 18-Feb-97 4.5 30.3 1.3 4.5 16.7 54.5
3 7 13-Jun-00 3.3 28.1 0 3.3 4.3 59.3
3 8 21-Apr-06 5.9 28.4 0 0 0 59.3
aAll intervals refer to the intervals between the prior and current examinations. bBody mass index: weight (kg)/height (m)2.
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demographic variables plus the health behavior variables
of smoking, alcohol consumption, physical activity, and
family history of type-2 diabetes.
The severity of body weight variable (BMI model),
the number of years of exposure to the obesity variable
(the duration of the obesity model), and the obese-years
variable (the obese-years model) were each grouped
into a number of categories. For the BMI model, BMI
530 kg/m2 (not obese) was used as a reference category.
For those with BMI ]30 kg/m2 (obesity), having the dura-
tion of obesity (]1 year) and]1 obese-years, 10 categories
were defined based on deciles, again, similar to the categories
used in the previous study (9) for that sake of comparison.
The goodness of fit of the three models was compared using
Akaike’s information criterion (AIC), computed as 2
(log-likelihood)2 (numberof estimated parameters), with
a lower AIC indicating a better fit (22). All statistical
analysis was conducted using Stata version 11 (23).
Results
Characteristics of the participants
During 152,700 person-years of follow-up, 35% of
participants (1,786 out of 5,132 eligible participants)
were identified as obese (Table 2). For those who were
ever obese during of follow-up, the mean cumulative
years lived with obesity was approximately 15 years
(range 135 years) and the mean cumulative obese-years
was 72 (range 2626 obese-years).
Incidence rate of type-2 diabetes
During the study follow-up, 903 (18%) participants died or
1,127 (22%) were lost to follow-up and 685 (13%) of the
participants were diagnosed with type-2 diabetes. A total
of 3,544 participants were censored at the end of the
study. The incidence rate of type-2 diabetes was 4.5 per
1,000 person-years. The incidence rates of type-2 diabetes
increased as the number of obese-years increased and were
2.2, 8.3, 9.4, 15.9, and 23.6 for the obese-years categories
of 0, and 124.9, 2549.9, 5074.9, and 75 obese-years,
respectively (Fig. 1).
Hazard ratios for type-2 diabetes
The adjusted HRs of type-2 diabetes for the categories of
124.9, 2549.9, 5074.9, and ]75 obese-years were
2.50 (95% CI: 1.853.37), 2.94 (95% CI: 2.044.24), 5.09
(95% CI: 3.567.26), and 6.05 (95% CI: 4.657.89),
respectively, compared with zero obese-years (Model 2).
A doseresponse relationship was observed (pB0.001).
When analyzing the continuous variable of obese-years,
the HR for the total population was 1.06 (95% CI: 1.05
1.07) per additional 10 obese-years (Table 3). An interac-
tion was observed between obese-years and smoking
status (pB0.001), but not with gender.
Comparing the different body weight metrics
using AIC
Table 4 shows a comparison of the goodness of fit for
the models for three different constructs of body weight
(obese-years, the duration of obesity and BMI). The models
were compared using the AIC, examined separately for
each model as an additive effect. In all population groups
(total population, men/women, and current smokers and
never/ex-smokers), the AIC score was lower in the model
with the obese-years construct compared with other
models, which suggests that the obese-years metric is the
40.0
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Fig. 1. The incidence of type-2 diabetes (events/1,000 person-years), according to cumulative obese-years, overall, and
separately stratified by sex and by smoking status.
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best model for estimating the risk of type-2 diabetes
compared with other two models of BMI and the duration
of obesity. This superior fit of the obese-years model was
particularly observed in women and smokers.
Discussion
Using a contemporary population cohort study, the FOS,
our analysis confirmed our previous findings, using the
original cohort of FHS, that an obese-years construct
yields a better estimation of the risk of incident type-2
diabetes than a construct based only on either BMI or the
duration of obesity. In both the FHS (baseline 1948) and
FOS (baseline 1971), a dose-response relationship was
clearly observed. For every additional 10 obese-years, the
risk of type-2 diabetes increased by approximately 7%
(95% CI: 59%). This finding has important clinical and
public health implications for obesity prevention strate-
gies and future studies of the burden of disease associated
with the adverse impact of obesity.
We argue that combining both the severity and the
duration of obesity into a single construct of obese-years
provided not only a better construct for estimating type-2
diabetes and cardiovascular disease (13), but also a better
construct for estimating the risk of all-cause and cause-
specific mortality compared to using the current con-
structs of BMI or obesity duration (24). It is recommended
that the usefulness of the obese-years construct should
be tested for estimating the health outcomes for other
Table 2. Characteristic of the population included in analysisa
Participants characteristics Number % Mean Range
Eligible sample 5,132
Participants ever obese during study follow-upa 1,786 35
Age at baseline; years 37 585
Sex: men 2,671 52
Ethnicity: Caucasian 5,121 99
Marital status
Single 332 6
Married 4,417 86
Widowed, divorced or separated 386 8
Educational level (year of schooling) 14 years 130
Health behavior
Smoking status at baseline: yes 2,221 43
Ever smoking during study follow-up 2,480 48
Physical activity at baseline
Slight physical activity 2,914 56 5.4 h/day
Moderate physical activity 2,837 54 3.8 h/day
Heavy physical activity 1,169 22 1.7 h/day
Alcohol drinking at baseline; glass/week 1,273 59
Wine 2,537 49
Beer 2,429 47
Cocktail 3,458 67
Biochemical characteristics
Serum cholesterol LDL at baseline; mg/100 ml 125 39403
Serum cholesterol HDL at baseline; mg/100 ml 56 9132
Fasting Blood glucose at baseline; mg/100 ml 101 60193
Body weight characteristics
BMI at baseline; kg/m2 25 1454
Underweight (B18.5 kg/m2) 130 3
Normal weight (18.524.9 kg/m2) 2,662 52
Overweight (2529.9 kg/m2) 1,709 33
Obese (]30 kg/m2) 619 12
Cumulative obesity duration; yearsb 15 135
Cumulative obese-yearsb 72 2636
Incidence rate of type-2 diabetes per 1,000 person-years 4.5
aParticipants were free from existing diabetes at study baseline. bFor those who were obese during study follow-up.
Estimating the risk of type-2 diabetes using obese-years
Citation: Glob Health Action 2016, 9: 30421 - http://dx.doi.org/10.3402/gha.v9.30421 5
(page number not for citation purpose)
conditions, such as cancer, that have shown a limited
association with the severity of obesity (25).
In this study, using a contemporary population cohort,
we have observed that there is no difference between men
and women in the risk of developing type-2 diabetes. This
contrasts with the previous study using the origin cohort
of the FHS, which found the risk of type-2 diabetes
increased with additional obese-years more strongly
for men than for women (9). Although the previous
study further showed a relatively similar effect of obese-
years for smokers and non-smokers, this analysis found
a higher risk of type-2 diabetes associated with the
Table 3. The hazard ratio (95% confidence interval) of type-2 diabetes per 10 obese-years or according to obese-years category
Model 1 Model 2
A. Continuous obese-yearsa
All sample 1.07 (1.061.08) 1.06 (1.051.07)
Men 1.07 (1.051.09) 1.06 (1.041.08)
Women 1.07 (1.061.08) 1.06 (1.051.07)
Current smokers 1.11 (1.071.15) 1.10 (1.061.15)
Never/ex-smokers 1.07 (1.061.08) 1.06 (1.051.07)
B. Categorical obese-years
All sample
0 1 1
124.9 2.75 (2.063.68) 2.50 (1.853.37)
2549.9 3.09 (2.174.40) 2.94 (2.044.24)
5074.9 5.45 (3.887.65) 5.09 (3.567.26)
]75 6.72 (5.208.68) 6.05 (4.657.89)
P value test trend p0.001 p0.001
Men
0 1 1
124.9 2.26 (1.543.31) 2.11 (1.433.13)
2549.9 3.05 (1.964.75) 2.90 (1.844.57)
5074.9 5.11 (3.327.87) 4.98 (3.197.76)
]75 5.02 (3.487.24) 4.24 (2.916.19)
P value test trend p0.001 p0.001
Women
0 1 1
124.9 3.54 (2.285.51) 3.07 (1.904.96)
2549.9 2.99 (1.655.43) 2.94 (1.595.46)
5074.9 6.02 (3.4810.43) 5.27 (2.939.46)
]75 8.99 (6.2612.90) 8.88 (6.1412.85)
P value test trend p0.001 p0.001
Current smokers
0 1 1
124.9 2.14 (0.895.14) 1.89 (0.754.80)
2549.9 3.41 (1.1210.32) 3.47 (1.1510.50)
5074.9 4.49 (1.5013.43) 4.83 (1.7613.25)
]75 17.96 (8.8036.66) 15.50 (6.9334.67)
P value test trend p0.001 p0.001
Never/ex-smokers
0 1 1
124.9 2.83 (2.083.84) 2.59 (1.883.55)
2549.9 3.08 (2.124.47) 2.92 (1.994.29)
5074.9 5.44 (3.807.79) 5.13 (3.527.46)
]75 6.08 (4.637.99) 5.54 (4.187.35)
P value test trend p0.001 p0.001
Model 1 is adjusted for the age, sex, marital status, and educational level of the entire sample and for the sample of current smokers or
never/ex-smokers; for the sample of men or women, it is adjusted for age, marital status, and educational level. Model 2 is adjusted for
the age, sex, marital status, educational level, current smoking status, alcohol consumption, physical activity, and family history of
diabetes for the entire sample; for the sample of men or women, the model is adjusted for all those variables except the variable of sex;
and for current smokers and never/ex-smokers, it is also adjusted for all those variables, except for smoking status. aHazard ratios refer to
the increase in type-2 diabetes risk associated with each additional 10 obese-years.
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obese-years construct for smokers than for non-smokers.
Most smokers tend to be leaner, but weight loss among
them appears to signal a greater amount of smoking and
often ill health (26). Consequently, the effect of obesity in
smokers may be underestimated.
The strength of this study is the use of the more
contemporary long-term FOS, where the prevalence of
obesity and type-2 diabetes more likely reflects current
obesity trends compared with the previous study (9). In
FOS, body weight, cofactors, the outcome of diabetes, and
mortality were also measured regularly. Most variables
were analyzed as time-dependent variables to consider
any variations or fluctuations of the value of the variable
during the study follow-up. Moreover, a comprehensive
number of potential confounders were also adjusted in the
analysis, including current smoking status, the number of
cigarettes smoked per day, and physical activity.
The main limitation of this study is related to the nature
of FOS, for which the interval between examinations was
relatively long, between 3 and 8 years. This is in contrast
to the FHS, in which the interval between examinations
was approximately 2 years. Body weight status and other
covariates were not available during these intervals,
and this study relied on the assumption that the value
was constant during examination intervals. In addition,
although we have adjusted for most confounders, some,
such as diet, are still not included in the analysis. Moreover,
the population of this study is relatively homogeneous and
Caucasian. Therefore, this study may not be generalizable
to other ethnic populations. Another limitation is that
BMI was the only measure of obesity. Prior studies (27, 28)
have demonstrated that waist circumference can be a
better predictor of metabolic outcome, such as diabetes,
which may imply that waist-circumference-years might be
a better construct than obese-years.
Conclusions
Obese-years was confirmed as a better construct for
estimating the risk of type-2 diabetes compared with the
previous models based solely on either the duration or
severity of obesity. The findings also support the use
of the obese-years construct for future studies analyzing
the total burden of obesity. The burden of obesity may be
underestimated if the degree and duration of obesity are
not taken into account.
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Paper context
Our previous study demonstrated that an obese-years
construct is a better predictor of risk of diabetes than the
severity of body weight alone. However, these risk estimates
were derived from a relatively old population cohort study of
the original FHS that initiated in 1948. Here we validate in a
more contemporary cohort study of the FOS. We recon-
firmed that the obese-years construct is strongly associated
with increased risk of type-2 diabetes. We suggested that
obese-years should be considered in future estimations of the
burden of disease associated with obesity.
Table 4. Comparison the AIC value of BMI, the duration of obesity, and the obese-years metric as predictors of the risk for
type-2 diabetes
Sex Smoking status
Models All sample Men Women Current smokers Never/ex-smokers
BMI 5,675 2,835 2,283 511 4,898
The duration of obesity 5,699 2,852 2,295 525 4,909
Obese-years 5,672 2,842 2,274 510 4,894
Each model analyses the obesity exposure measure categorized into 11 categories; 1 ‘not obese’, and 211 are deciles of obesity
exposure. For the entire sample, the models are adjusted for sex, age, marital status, education, smoking status, alcohol consumption,
physical activity, and family history of type-2 diabetes subjects. For the sample of men or women, all the above variables are adjusted for,
except the variable of sex. For the sample of current smokers or never/ex-smokers, all the above variables are also adjusted, except the
variable of smoking status.
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